60
Participants
Start Date
November 30, 2011
Primary Completion Date
April 30, 2014
Study Completion Date
April 30, 2014
Extrafine treatment (Clenilexx(R) or Foster(R))
Following the initial evaluation (cross-sectional) patients will be switched to an extrafine equipotent dose of the same compound (extrafine beclomethasone dipropionate - Clenilexx(R) - if the patient was on ICS) or combination (extrafine beclomethasone dipropionate/formoterol - Foster(R) - if the patient was on ICS/LABA combination). After 3-months patients will be reassessed for lung function and asthma control
Hospital Grosshansdorf, Großhansdorf
Research Centre on Asthma and COPD, University of Ferrara, Ferrara
Chiesi Farmaceutici S.p.A.
INDUSTRY
Università degli Studi di Ferrara
OTHER